Brief: Moberg Pharma July-Sept EBITDA Turns To Profit Of SEK 24.4 Mln
Nov 10 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* JULY-SEPT NET REVENUE SEK 50.5 MILLION (15.6) *
* JULY-SEPT EBITDA SEK 24.4 MILLION (-3.0) *
Source text for Eikon: ID:nWkr3X83Mz
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains